Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Avalo Therapeutics Inc (AVTX)

Avalo Therapeutics Inc (AVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants GlobeNewswire - Tue Nov 12, 6:00AM CST

AVTX : 9.09 (+3.18%)
Avalo Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire - Mon Nov 11, 6:00AM CST

AVTX : 9.09 (+3.18%)
Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates GlobeNewswire - Thu Nov 7, 6:00AM CST

AVTX : 9.09 (+3.18%)
Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa GlobeNewswire - Tue Oct 8, 6:00AM CDT

AVTX : 9.09 (+3.18%)
Origin Materials and Avantium to Accelerate the Mass Production of FDCA and PEF for Advanced Chemicals and Plastics Business Wire - Tue Feb 21, 2023

Origin Materials, Inc. (“Origin” and “Origin Materials”) (NASDAQ: ORGN, ORGNW), the world’s leading carbon negative materials company with a mission to enable the world’s transition to sustainable...

ORGN : 1.0500 (+7.87%)
ORGNW : 0.1035 (+21.91%)
AVTX : 9.09 (+3.18%)
Avalo Reports Second Quarter 2022 Financial Results and Provides Business Updates Globe Newswire - Thu Aug 4, 2022

Transferred anti-IL 18 monoclonal antibody product (AVTX-007) to Apollo Therapeutics in July with the approximate $15 million of upfront payment received...

AVTX : 9.09 (+3.18%)
Avalo Therapeutics Announces First Patient Dosed in the AVTX-803 Pivotal Trial (LADDER) for the Treatment of Leukocyte Adhesion Deficiency Type II (LAD II) Globe Newswire - Tue Aug 2, 2022

Topline Pivotal trial results expected 1H2023...

AVTX : 9.09 (+3.18%)
Avalo Therapeutics Transfers Anti-IL-18 Antibody, AVTX-007 (camoteskimab) to Apollo Therapeutics Globe Newswire - Mon Aug 1, 2022

Avalo to receive an approximately $15 million upfront payment, up to $74 million in milestone payments.Apollo to lead continued clinical development of...

AVTX : 9.09 (+3.18%)
Avalo Therapeutics Announces One-for-Twelve Reverse Stock Split Globe Newswire - Wed Jul 6, 2022

WAYNE, Pa. and ROCKVILLE, Md., July 06, 2022 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced a one-for-twelve reverse stock...

AVTX : 9.09 (+3.18%)
Avalo to Present at the 2022 Jefferies Healthcare Conference Globe Newswire - Thu Jun 2, 2022

WAYNE, Pa. and ROCKVILLE, Md., June 02, 2022 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D.,...

AVTX : 9.09 (+3.18%)

Barchart Exclusives

Bearish on the Market? 2 Defensive Stocks for Maximum Portfolio Protection. Barchart - 1 hour ago
As economic growth is anticipated to slow, UBS highlights these two dividend-paying defensive stocks as smart picks, shifting focus away from cyclical stocks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot